An ActRIIA fusion protein got FDA approved for PAH treatment
Mar 28 2024Reviewed by Maria Osipova On March 26th, the US FDA granted approval for Merck’s WINREVAIR™ (sotatercept-csrk), marking a ...
Tag: Pulmonary Arterial Hypertension
Investigators Capture A “Molecular Snapshot” To Illuminate The Origins Of Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (PAH) is a rare and incurable disease of the lung arteries that causes early death. In PAH, ...
